Cardiogenic embolism to the brain

The Lancet

Volumn 339, Issue 8793, 1992, Pages 589-594

  Hart, R G ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DOXORUBICIN; FIBRINOLYTIC AGENT; HEPARIN; WARFARIN;

BRAIN EMBOLISM; HEART DISEASE; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SHORT SURVEY; STROKE; SUBCUTANEOUS DRUG ADMINISTRATION;

ECHOCARDIOGRAPHY; FIBRINOLYTIC AGENTS; HEART DISEASES; HUMAN; INTRACRANIAL EMBOLISM AND THROMBOSIS;

EID: 0026602738     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)90873-2     Document Type: Article

References (36)

1. Cardiogenic brain embolism
2. Cardiogenic brain embolism second report of the Cerebral Embolism Task Force
3. Cardiac sources of embolism and cerebral infarction: clinical consequences and vascular concomitants
4. Predisposing factors for cerebral infarction: the Oxfordshire community stroke project
5. One-year outcome after cerebral infarction in whites, blacks, and Hispanics
6. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study
7. Stroke incidence and risk factors for stroke in Copenhagen, Denmark
8. Echocardiographic evaluation of patients with clinically suspected arterial emboli
9. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology
10. Transesophageal echocardiography in the detection of potential cardiac source of embolism in stroke patients
11. The recognition and embolic potential of intraaortic atherosclerotic debris.
12. Protruding atheromas in the thoracic aorta and systemic embolization
13. Transesophageal echocardiography in the detection of intracardiac embolic sources in patients with transient ischemic attacks
14. The Stroke Prevention in Atrial Fibrillation Study: final results
15. Pathogenesis of anterior circulation stroke in patients with nonvalvular atrial fibrillation: the Lausanne Stroke Registry
16. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study
17. Canadian Atrial Fibrillation Anticoagulation Study
18. Interim analysis of the VA Cooperative Study: stroke prevention in nonrheumatic atrial fibrillation
19. The effect of low-dose warfarin on the risk of stroke in nonrheumatic atrial fibrillation
20. Prevention of stroke in atrial fibrillation
21. Predictors of thromboembolism in atrial fibrillation clinical features of patients at risk
22. The natural history of lone atrial fibrillation: a population-based study over three decades
23. Predictors of thromboembolism in atrial fibrillation echocardiographic features of patients at risk
24. Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study
25. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2
26. Cerebrovascular events after myocardial infarction: analysis of the GISSI trial
27. Left ventricular thrombus in anterior acute myocardial infarction after thrombolysis: a GISSI-2 connected study
28. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction
29. Randomised controlled trial of subcutaneous calcium-heparin in acute myocardial infarction
30. The natural history of left ventricular thrombus in myocardial infarction: a rationale in support of masterly inactivity
31. The effects of long-term antithrombotic treatment on left ventricular thrombi in patients after acute myocardial infarction
32. Atrial septal aneurysm: recognition and clinical relevance
33. A plea for a clinical trial of anticoagulation in dilated cardiomyopathy
34. Prevalence of patent foramen ovale in patients with stroke
35. Very low doses of warfarin can prevent thrombosis in central venous catheters
36. Cardioembolic stroke, immediate anticoagulation and brain hemorrhage